Utilizing three different animal models expressing the soluble human NKG2D ligand sMICB, we clearly distinguished the differential impact of soluble human NKG2D ligands on the potential of initial tumor formation versus the progression of established tumors. The gene discussed is KLRK1; the disease is neoplasm.